These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 9243537)

  • 1. Seven ways to increase power without increasing N.
    Hansen WB; Collins LM
    NIDA Res Monogr; 1994; 142():184-95. PubMed ID: 9243537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
    Santiago-Delefosse M; Cahen F; Coeffin-Driol C
    Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifetime earnings patterns, the distribution of future Social Security benefits, and the impact of pension reform.
    Bosworth B; Burtless G; Steuerle E
    Soc Secur Bull; 2000; 63(4):74-98. PubMed ID: 11641991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical sampling and hypothesis testing in orthopaedic research.
    Bernstein J; McGuire K; Freedman KB
    Clin Orthop Relat Res; 2003 Aug; (413):55-62. PubMed ID: 12897596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of trial size on statistical power.
    Bates BT; Dufek JS; Davis HP
    Med Sci Sports Exerc; 1992 Sep; 24(9):1059-65. PubMed ID: 1406191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mid-course sample size modification in clinical trials based on the observed treatment effect.
    Jennison C; Turnbull BW
    Stat Med; 2003 Mar; 22(6):971-93. PubMed ID: 12627413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What to do if statistical power is low? A practical strategy for pre-post-designs].
    Müller J; Manz R; Hoyer J
    Psychother Psychosom Med Psychol; 2002; 52(9-10):408-16. PubMed ID: 12355348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fallacy of enrolling only high-risk subjects in cancer prevention trials: is there a "free lunch"?
    Baker SG; Kramer BS; Corle D
    BMC Med Res Methodol; 2004 Oct; 4():24. PubMed ID: 15461821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed analysis of the relative power of direct and indirect association studies and the implications for their interpretation.
    Moskvina V; O'Donovan MC
    Hum Hered; 2007; 64(1):63-73. PubMed ID: 17483598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How many do I need? Basic principles of sample size estimation.
    Devane D; Begley CM; Clarke M
    J Adv Nurs; 2004 Aug; 47(3):297-302. PubMed ID: 15238124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis with missing data in drug prevention research.
    Graham JW; Hofer SM; Piccinin AM
    NIDA Res Monogr; 1994; 142():13-63. PubMed ID: 9243532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical power and estimation of the number of required subjects for a study based on the t-test: a surgeon's primer.
    Livingston EH; Cassidy L
    J Surg Res; 2005 Jun; 126(2):149-59. PubMed ID: 15919413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical power and effect sizes of clinical neuropsychology research.
    Bezeau S; Graves R
    J Clin Exp Neuropsychol; 2001 Jun; 23(3):399-406. PubMed ID: 11419453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.